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Background
To evaluate clinical and immunological outcomes and
the associated factors among adult patients receiving
ART at MJAP, Uganda.
Methods
A retrospective cohort analysis of patient data on ART
between August 2005 and June 2009 at Mulago Hospital
AIDS (ISS) clinic.
Changes in Body Mass Index (BMI) and CD4 cell count,
incidence of Opportunistic Infections (OIs) and mortality
were compared with the patients’ socio-demographics,
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regimen and adherence levels. Odds ratios, 95% confi-
dence intervals, chi square tests, logistic regression and
Cox proportional hazard model were used for analysis.
Results
Of the 4,824 patients on ART, 65% (3,120) were female,
median age; 33 years (IQR: 28-40). Total follow up time
was 5824.9 Person Years (PY). Median CD4+ count and
BMI at ART initiation was 138 cells/mm
3 (IQR: 60-200)
and 21.2 kg/m
2 (IQR 19.2-23.7) respectively. 10.6%
developed OIs, 239 (5%) patients died. Incidence of
death was 4.12/100 PY (95% CI 3.63-4.68). Gain in CD4
count and BMI was observed in 68% and 63% of the
patients respectively. Median increase in CD4 count was
174 cells/mm
3 (IQR 96-278) and mean increase in BMI
was 1.5 kg/m
2 (S.D 2.82).
Increase in CD4 count and BMI was associated with
increased income, adherence ≥ 95%, WHO stages III & IV
and CD4 count < 100 (P < 0.05). The risk of developing
an OI was associated with CD4 count < 100, WHO stages
III & IV (P < 0.001) and decreasing levels of education
(c
2 for trend = 7.7 (df) = 1, P = 0.005). Mortality
was higher in patients in WHO stage III & IV (H.R 2.57,
P < 0.001) and lower in patients with CD4 count ≥100,
(H.R 0.32, P < 0.001) and adherence ≥ 95% (HR 0.55,
P < 0.001).
Discussion
Early initiation of ART, good adherence, improved income
and education status are associated with increased survival
and positive clinical and immunological outcomes among
patients on ART.
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